Terms: = Brain cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2 AND Prognosis
166 results:
1. Predicting the prognosis of glioma patients with tert promoter mutations and guiding the specific immune profile of immune checkpoint blockade therapy.
Cao W; Lan J; Hu C; Kong J; Xiang L; Zhang Z; Sun Y; Zeng Z; Lei S
Aging (Albany NY); 2024 Mar; 16(6):5618-5633. PubMed ID: 38499392
[TBL] [Abstract] [Full Text] [Related]
2. Adult epithelioid glioblastoma exhibits an extremely poor prognosis and high frequency of SWI/SNF complex mutation: Insights from a retrospective study.
Xi S; Jiang S; Li H; Huang Q; Lu J; Zhang X; Li Z; Zeng J
Int J Cancer; 2024 Jul; 155(1):172-183. PubMed ID: 38411299
[TBL] [Abstract] [Full Text] [Related]
3. MGMT unmethylation and high levels of CD47 and TIGIT indicate a poor prognosis in adult diffuse gliomas.
Ma L; Shi Y; Li C; Deng B; Jiang J; Cao Y; Wang L; Li H
Front Immunol; 2024; 15():1323307. PubMed ID: 38404571
[TBL] [Abstract] [Full Text] [Related]
4. Artificial Intelligence Imaging for Predicting High-risk Molecular Markers of Gliomas.
Liang Q; Jing H; Shao Y; Wang Y; Zhang H
Clin Neuroradiol; 2024 Mar; 34(1):33-43. PubMed ID: 38277059
[TBL] [Abstract] [Full Text] [Related]
5. Optimizing the risk stratification of astrocytic tumors by applying the cIMPACT-NOW Update 3 signature: real-word single center experience.
Molica C; Gili A; Nardelli C; Pierini T; Arniani S; Beacci D; Mavridou E; Mandarano M; Corinaldesi R; Metro G; Gorello P; Giovenali P; Cenci N; Castrioto C; Lupattelli M; Roila F; Mecucci C; La Starza R
Sci Rep; 2023 Nov; 13(1):20101. PubMed ID: 37973912
[TBL] [Abstract] [Full Text] [Related]
6. Variant allelic frequencies of driver mutations can identify gliomas with potentially false-negative MGMT promoter methylation results.
McCord M; Jamshidi P; Thirunavu V; Santana-Santos L; Vormittag-Nocito E; Dittman D; Parker S; Baczkowski J; Jennings L; Walshon J; McCortney K; Galbraith K; Zhang H; Lukas RV; Stupp R; Dixit K; Kumthekar P; Heimberger AB; Snuderl M; Horbinski C
Acta Neuropathol Commun; 2023 Nov; 11(1):175. PubMed ID: 37919784
[TBL] [Abstract] [Full Text] [Related]
7. Comparative Analysis of the Prognostic Significance of IDH,tert, EGFR and MGMT Status in Patients with Adult Non-H3-Altered Grade 4 Gliomas: A Prospective Cohort Study.
Alimohamadi M; Larijani A; Pour-Rashidi A; Farzin M; Ebrahimi H; Rahmani M; Hendi K; Yarandi KK; Aghajanian S; Shirani M
World Neurosurg; 2024 Jan; 181():e628-e639. PubMed ID: 37914076
[TBL] [Abstract] [Full Text] [Related]
8. Overexpression of Podoplanin Predicts Poor prognosis in Patients With Glioma.
He J; Zhang G; Yuan Q; Wang S; Liu Z; Wang M; Cai H; Wan J; Zhao B
Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):295-303. PubMed ID: 37093708
[TBL] [Abstract] [Full Text] [Related]
9. Association of the Telomerase Reverse Transcriptase rs10069690 Polymorphism with the Risk, Age at Onset and prognosis of Triple Negative Breast cancer.
Zins K; Peka E; Miedl H; Ecker S; Abraham D; Schreiber M
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768147
[TBL] [Abstract] [Full Text] [Related]
10. Clinical and genomic features in patients with second primary glioblastoma following first primary renal cell carcinoma.
Zhang GT; Liu Q; Zuo FX; Liu HJ; Wang SQ; Yuan Q; Liu AS; Hu K; Meng XL; Wang WJ; Qian HP; Wan JH; Cai HQ
BMC Cancer; 2023 Jan; 23(1):104. PubMed ID: 36717819
[TBL] [Abstract] [Full Text] [Related]
11. Clinico-pathological and epigenetic heterogeneity of diffuse gliomas with FGFR3::TACC3 fusion.
Métais A; Tauziède-Espariat A; Garcia J; Appay R; Uro-Coste E; Meyronet D; Maurage CA; Vandenbos F; Rigau V; Chiforeanu DC; Pallud J; Senova S; Saffroy R; Colin C; Edjlali M; Varlet P; Figarella-Branger D;
Acta Neuropathol Commun; 2023 Jan; 11(1):14. PubMed ID: 36647073
[TBL] [Abstract] [Full Text] [Related]
12. Imaging features of localized IDH wild-type histologically diffuse astrocytomas: a single-institution case series.
Kibe Y; Motomura K; Ohka F; Aoki K; Shimizu H; Yamaguchi J; Nishikawa T; Saito R
Sci Rep; 2023 Jan; 13(1):23. PubMed ID: 36646712
[TBL] [Abstract] [Full Text] [Related]
13. The clinicopathological features and prognosis of multifocal high-grade gliomas in adults with
Zhao Y; Chen Y; Wang L; Gao Y; Xu J
Neurosciences (Riyadh); 2023 Jan; 28(1):42-47. PubMed ID: 36617452
[TBL] [Abstract] [Full Text] [Related]
14. Molecular Characterization of Adult Tumors Diagnosed as Cerebellar Glioblastomas Identifies Subgroups Associated With prognosis.
Picart T; Poncet D; Barritault M; Bauchet L; Zouaoui S; Guyotat J; Gabut M; Fina F; Honnorat J; Figarella-Branger D; Pallud J; Ducray F; Meyronet D; ;
Am J Surg Pathol; 2023 Jan; 47(1):131-144. PubMed ID: 36418240
[TBL] [Abstract] [Full Text] [Related]
15. Role of tert mutation for treatment prognosis in patients with IDH-negative anaplastic astrocytoma.
Belyaev AY; Kobyakov GL; Shmakov PN; Telysheva EN; Strunina YV; Usachev DY
Zh Vopr Neirokhir Im N N Burdenko; 2022; 86(5):21-27. PubMed ID: 36252190
[TBL] [Abstract] [Full Text] [Related]
16. The correlation analysis of tert promoter mutations with IDH1/2 mutations and 1p/19q detected in human gliomas.
Xu J; Xu FP; Liu ZH; Cui Q; Zhang KP; Li Z
Medicine (Baltimore); 2022 Jul; 101(29):e29668. PubMed ID: 35866817
[TBL] [Abstract] [Full Text] [Related]
17. Telomerase Reverse Transcriptase Promoter Mutations in A Cohort Of Adult Gliomas - Clinicopathological Correlates.
Balakumar S; Pai R; Chacko AG; Patel B; Nancy R; Balakrishnan R; Sarkar S; Sampath G; Chacko G
Neurol India; 2022; 70(3):953-959. PubMed ID: 35864624
[TBL] [Abstract] [Full Text] [Related]
18. Gliomas molecular markers: importance in treatment, prognosis and applicability in brazilian health system.
Soldatelli JS; Oliveira IM; Kneubil MC; Henriques JAP
An Acad Bras Cienc; 2022; 94(3):e20211075. PubMed ID: 35766600
[TBL] [Abstract] [Full Text] [Related]
19. [Prognostic value of tert mutation in adults with primary glioblastomas. Preliminary results].
Zolotova SV; Anoshkin KI; Absalyamova OV; Makashova ES; Belyashova AS; Telysheva EN; Golanov AV
Zh Vopr Neirokhir Im N N Burdenko; 2022; 86(3):33-40. PubMed ID: 35758076
[TBL] [Abstract] [Full Text] [Related]
20. Gliomas: Genetic alterations, mechanisms of metastasis, recurrence, drug resistance, and recent trends in molecular therapeutic options.
Kannan S; Murugan AK; Balasubramanian S; Munirajan AK; Alzahrani AS
Biochem Pharmacol; 2022 Jul; 201():115090. PubMed ID: 35577014
[TBL] [Abstract] [Full Text] [Related]
[Next]